The outlook of companies tied to the drug's legacy presents a complex investment landscape. While the initial surge generated substantial gains, generic alternatives have significantly diminished sales . https://porn046286.blogzag.com/85150658/copyright-s-flagship-product-and-pharma-a-speculative-opportunity